GNH USA

Europe — EMA

Mypaid (Dihydrocodeine Tartrate)

GNH USA supplies Mypaid (Dihydrocodeine Tartrate), an opioid analgesic for moderate pain and cough suppression. Request a quote for global supply today.

Request sourcing

1
Pack/s

What is Dihydrocodeine Tartrate?

Dihydrocodeine tartrate, the active ingredient in Mypaid, is an opioid analgesic presented as an oral dosage form for oral use. It is indicated for the relief of moderate pain and for cough suppression in appropriate patients.

GNH USA supplies Mypaid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Dihydrocodeine Tartrate used for?

Mypaid is an opioid analgesic that acts on the central nervous system to alleviate pain and suppress cough. - Moderate pain: provides relief for conditions such as dental or musculoskeletal pain. - Cough: reduces the frequency and intensity of cough associated with respiratory infections. - Post‑operative pain: helps manage pain after minor surgical procedures.

What are the side effects of Dihydrocodeine Tartrate?

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness or unsteadiness. - Dry mouth: reduced salivation leading to a parched feeling. - Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that may be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Seizures: uncontrolled electrical activity in the brain. - Dependence or withdrawal: physical or psychological reliance on the drug. - Hepatic dysfunction: liver enzyme abnormalities or injury.

What precautions apply to Dihydrocodeine Tartrate?

Before prescribing Mypaid, clinicians should evaluate patient history and potential risk factors. - Assess pain severity: ensure the drug is appropriate for the level of pain. - Avoid in respiratory depression: contraindicated for patients with compromised breathing. - Monitor for dependence: watch for signs of misuse or addiction. - Use caution in the elderly: increased sensitivity to sedative effects. - Avoid concomitant CNS depressants: limit use with alcohol, benzodiazepines, or other opioids. - Store at ambient temperature: keep in the original container, protect from moisture and light.

What does Dihydrocodeine Tartrate interact with?

Mypaid may interact with several medications, requiring careful management. Major Interactions (Avoid): - Other opioids: additive respiratory depression risk. - Benzodiazepines: enhanced sedation and respiratory suppression. - Alcohol: increased CNS depression. - Central nervous system depressants: synergistic sedative effects. - MAO inhibitors: potential for severe hypertension. Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may increase dihydrocodeine levels. - Anticholinergics: may exacerbate dry mouth. - Antihistamines: can augment drowsiness. - SSRIs: monitor for serotonin syndrome. - Diuretics: may affect blood pressure control.

Frequently asked questions

What is Mypaid used for?+
Mypaid contains dihydrocodeine tartrate and is prescribed to relieve moderate pain, such as dental or musculoskeletal discomfort, and to suppress cough associated with respiratory conditions. It is a prescription‑only opioid analgesic used under medical supervision.
How does dihydrocodeine tartrate work?+
Dihydrocodeine tartrate acts as an agonist at mu‑opioid receptors in the brain and spinal cord. Activation of these receptors reduces the transmission of pain signals and depresses the cough reflex, providing both analgesic and antitussive effects.
What is the usual dose of Mypaid?+
The appropriate dose of Mypaid is determined by the prescribing clinician based on the patient’s pain intensity, medical history, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions.
Is Mypaid safe during pregnancy or breastfeeding?+
Safety data for dihydrocodeine tartrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and only under direct medical advice.
How do I order Mypaid from GNH USA?+
To order Mypaid, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Mypaid compare with other opioid cough suppressants?+
Mypaid’s active ingredient, dihydrocodeine tartrate, offers both analgesic and antitussive properties, whereas codeine provides similar effects but may have a different potency profile. Dihydrocodeine is often considered slightly more potent than codeine for pain relief, but both share comparable safety considerations.
How should Mypaid be stored and handled?+
Mypaid should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.
How is Mypaid administered?+
Mypaid is taken orally, usually as a tablet, and should be swallowed whole with water unless otherwise directed by a healthcare professional. It is important to follow the prescriber’s dosing schedule and not to exceed the recommended amount.
What are the most serious risks associated with Mypaid?+
The most serious risks include respiratory depression, severe hypotension, allergic reactions such as anaphylaxis, seizures, and the potential for dependence or withdrawal syndrome. Patients should be monitored closely for these events, especially during initiation or dose changes.
Who should not use Mypaid?+
Mypaid should be avoided in individuals with known hypersensitivity to dihydrocodeine or other opioids, those with severe respiratory depression, untreated obstructive sleep apnea, or significant head injury. Caution is also advised for patients taking other central nervous system depressants.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Dihydrocodeine Tartrate
Route
Oral Use
Manufacturer
Sandoz Ltd
Origin
EU

Related products